Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
RXRX
Market Cap$1.98B
Close$
Share Statistics
| Market cap | $1.98 Billion |
|---|---|
| Enterprise Value | $1.64 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.58 |
| Beta | 0.0 |
| Outstanding Shares | 230,273,797 |
| Avg 30 Day Volume | 4,231,041 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.04 |
|---|---|
| PEG | -9.77 |
| Price to Sales | - |
| Price to Book Ratio | 5.01 |
| Enterprise Value to Revenue | 36.78 |
| Enterprise Value to EBIT | -4.68 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
ESG Score
No data
About Recursion Pharmaceuticals Inc
218 employeesRecursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patient...